Determinants of glycemic control in type 2 diabetes mellitus in Brazil: A sub-analysis of the longitudinal data from the BrazIian type 1 & 2 diabetes disease registry (BINDER)
Moreira, Rodrigo O., Vianna, André G.D., Ferreira, Graziela C., de Paula, Mauricio A.
Published in Primary care diabetes (01.08.2022)
Published in Primary care diabetes (01.08.2022)
Get full text
Journal Article
Improved glycaemic variability and time in range with dapagliflozin versus gliclazide modified release among adults with type 2 diabetes, evaluated by continuous glucose monitoring: A 12‐week randomized controlled trial
Vianna, Andre G. D., Lacerda, Claudio S., Pechmann, Luciana M., Polesel, Michelle G., Marino, Emerson C., Scharf, Mauro, Detsch, Josiane M., Marques, Kleber, Sanches, Claudia P.
Published in Diabetes, obesity & metabolism (01.04.2020)
Published in Diabetes, obesity & metabolism (01.04.2020)
Get full text
Journal Article
164-LB: A Randomized Controlled Trial to Compare the Glycemic Effects of Dapagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, and Gliclazide Modified Release, a Sulfonylurea, Assessed by Continuous Glucose Monitoring among People with Type 2 Diabetes
VIANNA, ANDRE G.D., SILVA DE LACERDA, CLAUDIO, MUNIZ PECHMANN, LUCIANA, GARCIA POLESEL, MICHELLE, CESTARI MARINO, EMERSON, CRISTINE DETSCH, JOSIANE, RAMOS MARQUES, KLEBER, PINHEIRO ROCHA, CLAUDIA
Published in Diabetes (New York, N.Y.) (01.06.2019)
Published in Diabetes (New York, N.Y.) (01.06.2019)
Get full text
Journal Article